Literature DB >> 12084811

The influence of intellectual disability on life expectancy.

A H Bittles1, B A Petterson, S G Sullivan, R Hussain, E J Glasson, P D Montgomery.   

Abstract

BACKGROUND: To date, relatively few representative data have been available to health planners and advocacy groups on the life expectancy of people with intellectual disability. A study of trends in the survival profiles of people with intellectual disability was undertaken to assist in the planning of appropriate medical and support services.
METHODS: Since 1953, the Disability Services Commission of Western Australia has maintained a database of persons diagnosed with intellectual disability. The database was used to calculate survival probabilities on a total of 8724 individuals, 7562 of whom were still alive at the time of sampling in December 2000.
RESULTS: Kaplan-Meier survival plots showed a strong negative association between severity of intellectual disability and survival, with median life expectancies of 74.0, 67.6, and 58.6 years for people with mild, moderate, and severe levels of handicap. Significant negative associations also were observed with male gender, Indigenous Australian parentage, and individuals diagnosed with a specific genetic disorder.
CONCLUSIONS: The findings indicate a major and expanding increase in the service requirements of this aging, intellectually disabled population during the past two generations.

Entities:  

Mesh:

Year:  2002        PMID: 12084811     DOI: 10.1093/gerona/57.7.m470

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  41 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Well-being of Sibling Caregivers: Effects of Kinship Relationship and Race.

Authors:  Eun Ha Namkung; Jan S Greenberg; Marsha R Mailick
Journal:  Gerontologist       Date:  2017-08-01

3.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

4.  Addressing Health Disparities in Adults with Developmental Disabilities.

Authors:  Andrea S Videlefsky; Jeffrey M Reznik; Janice T Nodvin; Harry J Heiman
Journal:  Ethn Dis       Date:  2019-06-13       Impact factor: 1.847

5.  Dental care among young adults with intellectual disability.

Authors:  Vijaya Kancherla; Kim Van Naarden Braun; Marshalyn Yeargin-Allsopp
Journal:  Res Dev Disabil       Date:  2013-03-15

6.  [Body weight and mental disorders : Results from a clinical psychiatric cross-sectional study of people with intellectual disabilities].

Authors:  M L Franke; M Heinrich; M Adam; U Sünkel; A Diefenbacher; T Sappok
Journal:  Nervenarzt       Date:  2018-05       Impact factor: 1.214

7.  Primary care of adults with severe and profound intellectual and developmental disabilities: Family physicians' perspectives on patient-physician relationships.

Authors:  Katherine Stringer; Bridget L Ryan; Amanda L Terry; Andrea Pike
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

8.  Intercellular competition and levels of development: The plasticity of inevitability.

Authors:  Robert B Eckhardt; Alex S Weller; Maciej Henneberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-12       Impact factor: 11.205

9.  Implementation challenges in end-of-life research with adults with intellectual and developmental disabilities.

Authors:  Teresa A Savage; Teresa Thalia Moro; Jackelyn Y Boyden; Allison A Brown; Karen L Kavanaugh
Journal:  Appl Nurs Res       Date:  2014-10-13       Impact factor: 2.257

10.  Fracture risk in people with developmental disabilities: results of a large claims data analysis.

Authors:  G Büchele; C Becker; I D Cameron; R Auer; D Rothenbacher; H H König; K Rapp
Journal:  Osteoporos Int       Date:  2016-08-24       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.